Title |
Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function
|
---|---|
Published in |
Journal of Thrombosis and Thrombolysis, December 2018
|
DOI | 10.1007/s11239-018-1779-y |
Pubmed ID | |
Authors |
Simon Correa, Marc P. Bonaca, Benjamin M. Scirica, Sabina A. Murphy, Erica L. Goodrich, David A. Morrow, Michelle L. O’Donoghue |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 7 | 18% |
Student > Master | 4 | 10% |
Researcher | 4 | 10% |
Student > Ph. D. Student | 4 | 10% |
Student > Postgraduate | 2 | 5% |
Other | 3 | 8% |
Unknown | 15 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 31% |
Neuroscience | 2 | 5% |
Sports and Recreations | 2 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Psychology | 1 | 3% |
Other | 3 | 8% |
Unknown | 18 | 46% |